Research has shown that the induction of cytokines and the subsequent expression of NF-kB can enhance tumor proliferation [115], cancer progression [116], the establishment of the pre-metastatic field [117], oncogenic recurrence, and increased resistance to therapy [118]. Here, NFKB1 is linked to cancer.